Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
United
Current Ratio
=
Current Asset
Current Liabilities
=
4.78 times
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e. Current Ration of 2 to 1).
In accordance with recently published financial statements United Therapeutics Corporation has Current Ratio of 4.78 times. This is 45.73% higher than that of Healthcare sector, and 15.18% higher than that of Drug Manufacturers - Other industry, The Current Ratio for all stocks is 95.9% lower than the firm.
Filter other Stocks by Current Ratio
Select Current Ratio Range
Current Range
Indicate Industry
Click to run this filter
Filter Other Equities
Current Ratio Comparison
United is rated third in current ratio category among related companies.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
Nasdaq United Therapeutics Corporation
-0.07%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
